Sériès E, Broustet J P, Boisseau M, Bricaud H
Arch Mal Coeur Vaiss. 1978 Oct;71(10):1135-42.
10 control subjects and 27 patients with prosthetic valves (15 with Björk aortic valves, 6 with mitral prostheses, 4 with aortic and mitral valves, 1 with a Björk mitral and a Starr aortic valve, and 1 with a Beall mitral valve) underwent, at intervals of 24 hours, two maximal exercise tests, initially without (day J) and subsequently with (day J + 2) propranolol in a dose of 80 mg/24 h, haemolysis and platelet function being assessed immediately before and immediately after each test. Exercise tolerance was not altered by propranolol in this dose, provided the heart size was not more than 1500 ml. Haemolysis, as assessed by the level of lactic dehydrogenase (LDH1) was increased by exercise, especially in the aortic prosthesis cases in which the LDH1 was increased by 21.6% (p less than 0.025). The increase was less marked under propranolol treatment, when it was 12.3% (p less than 0.05). Propranolol did not correct the platelet clumping caused by the prosthetic mitral valves, but did decrease platelet stickiness on exercise in the patients with prostheses (delta = -11.7%; p less than 0.05). Propranolol can not therefore be recommended for increased haemolysis if there is no demonstrable dysfunction of the prosthetic valve. Neither would we advise its use at present with the aim of reducing thrombotic accidents.
10名对照受试者和27名人工瓣膜患者(15名植入比约克主动脉瓣、6名植入二尖瓣假体、4名同时植入主动脉瓣和二尖瓣、1名植入比约克二尖瓣和斯塔尔主动脉瓣、1名植入比尔二尖瓣)每隔24小时进行两次最大运动测试,最初在未服用(第J天)、随后在服用(第J + 2天)80 mg/24 h剂量普萘洛尔的情况下进行,每次测试前后立即评估溶血和血小板功能。如果心脏大小不超过1500 ml,该剂量的普萘洛尔不会改变运动耐量。通过乳酸脱氢酶(LDH1)水平评估的溶血因运动而增加,尤其是在主动脉假体病例中,LDH1增加了21.6%(p < 0.025)。在普萘洛尔治疗下,增加幅度较小,为12.3%(p < 0.05)。普萘洛尔不能纠正人工二尖瓣引起的血小板聚集,但确实降低了假体患者运动时的血小板黏附性(变化量 = -11.7%;p < 0.05)。因此,如果人工瓣膜没有明显功能障碍,不建议使用普萘洛尔来减少溶血。目前我们也不建议为减少血栓形成事件而使用它。